John Vandermosten, CFA

Biotechnology Analyst at Zacks

Dyadic International Inc. is followed by the analyst listed above. The information above is solely for informational purposes, and is not intended as a solicitation to make investments. Please note that any opinions, estimates or forecasts regarding Dyadic International Inc.’s performance made by this analyst is his alone and does not represent opinions, forecasts or predictions of Dyadic International Inc. or its management. Dyadic International Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Zacks SCR has received compensation from Dyadic International Inc. directly or from an investor relations consulting firm engaged by Dyadic International Inc. for providing non-investment banking services to Dyadic International Inc. for a period of no less than one year and expects to receive quarterly payments totaling a maximum fee of $30,000 annually for such non-investment banking services provided to Dyadic International Inc. The non-investment banking services provided to Dyadic International Inc. includes the preparation of analyst reports, investor relations services, investment software, financial database analysis, organization of non-deal road shows, and attendance fees for conferences sponsored or co-sponsored by Zacks SCR.

Click Here For Analyst Report